Literature DB >> 6813269

Serum IgA: modulation of complement activation and induction of susceptibility to bacterial dissemination.

J M Griffiss.   

Abstract

Data are presented that support the conclusion that serum IgA functions as a regulatory Ig that modulates activation of complement by bacteria entering the circulation in showers of low inoculum from mucosal sites of colonization, and that preserves the antigenic mass by shunting such low inocula into macrophages and away from polymorphonuclear leukocytes, thus permitting immunologic processing. This regulation is an integral part of the physiologic immune response to environmental antigens and occurs during the peripheralization of the IgA response following stimulation of Peyer's patches and their analog in the lung. Down-regulation of complement mediated immune effector mechanisms by circulating IgA is balanced delicately. Pathologic states that increase the level of circulating IgA or decrease the phagocytic capacity of the monocyte/macrophage compartment may result in an oligospecific increase in susceptibility to bacterial dissemination. Fortuitous, co-temporal colonization of both gut and distal mucosal lymphoid tissue may result in augmentation of the serum IgA response to levels which induce monospecific susceptibility. This latter mechanism appears to account for the epidemic acquisition of susceptibility to disseminated meningococcal disease. A model of the relation of serum IgA to other components of mucosal immunity is presented.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813269     DOI: 10.1007/bf01666922

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  30 in total

1.  Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease.

Authors:  J M Griffiss; M A Bertram
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

2.  Gamma-M deficiency predisposing to meningococcal septicaemia.

Authors:  J R Hobbs; R D Milner; P J Watt
Journal:  Br Med J       Date:  1967-12-09

3.  Defective regulation of chemotaxis in cirrhosis.

Authors:  E C Maderazo; P A Ward; R Quintiliani
Journal:  J Lab Clin Med       Date:  1975-04

4.  Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity.

Authors:  A Nicholson; I H Lepow
Journal:  Science       Date:  1979-07-20       Impact factor: 47.728

5.  Immunological cross-reaction between a naturally occurring galactan, agarose, and an LPS locus for immune lysis of Neisseria meningitidis by human sera.

Authors:  J M Griffiss; D K Goroff
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Diarrhea due to Escherichia coli strain RDEC-1 in the rabbit: the peyer's patch as the initial site of attachment and colonization.

Authors:  J R Cantey; L R Inman
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

Review 7.  Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model.

Authors:  J M Griffiss
Journal:  Rev Infect Dis       Date:  1982 Jan-Feb

8.  Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.

Authors:  G H Lowell; L F Smith; J M Griffiss; B L Brandt; R P MacDermott
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  Role of serum IgA. Hepatobiliary transport of circulating antigen.

Authors:  M W Russell; T A Brown; J Mestecky
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  3 in total

1.  Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes.

Authors:  J Sancho; J Egido; F Rivera; L Hernando
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

2.  Enzymatic and antigenic characterization of immunoglobulin A1 proteases from Bacteroides and Capnocytophaga spp.

Authors:  E V Frandsen; J Reinholdt; M Kilian
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults.

Authors:  J M Griffiss; B L Brandt; P L Altieri; G B Pier; S L Berman
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.